Navigation Links
Allied Healthcare Products Reports Modest Profit for Quarter
Date:2/8/2011

ST. LOUIS, Feb. 8, 2011 /PRNewswire/ -- With its governmental markets still depressed, Allied Healthcare Products (Nasdaq: AHPI) earned a modest profit in the second quarter of fiscal year 2011 and improvement in its year-over-year performance.

Net income for the quarter ending December 31 was $117,000, or 1 cent per basic and diluted share, compared to $22,000, or zero cents per share, for the previous year's quarter. For the first two quarters of the fiscal year, net income was about $29,000, or zero cents per basic and diluted share, compared to a loss of $723,000, or a negative 9 cents per share, for the previous year's first two quarters. Allied earnings in the previous year were affected by a non-cash charge of $609,000 for a grant of stock options.

Sales for the second quarter totaled about $11.4 million, slightly below the mark set in the previous year's quarter. For the first six months of the fiscal year, sales increased by about $605,000, or 2.7 percent, to about $23.3 million.

Unanticipated costs of about $280,000 associated with the introduction of a new product depressed results for the quarter. Most of those costs were a one-time event.

In the first half of the fiscal year, prices for commodity materials such as brass and steel increased 8 percent. Still, Allied managed to hold overall purchased material costs to an increase of less than 1 percent. Also, the company reduced selling, general and administrative (SG&A) costs by about 10 percent for the quarter, the second consecutive quarter in which significant SG&A reductions were achieved."Our cost structure is strong, so we are well-positioned to take advantage of an upturn in the market," said Earl Refsland, Allied president and chief executive officer.

Allied Healthcare Products manufactures a variety of respiratory products used in the healthcare industry in a range of hospital and alternate care settings including sub-acute facilities, home healthcare and emergency medical care. Allied product lines include respiratory care products, medical gas equipment and emergency medical products. Allied products are marketed to hospitals, hospital equipment dealers, hospital construction contractors, home healthcare dealers and emergency medical product dealers.

"SAFE HARBOR" STATEMENT: Statements contained in this release that are not historical facts or information are "forward-looking statements."  Words such as "believe," "expect," "intend," "will," "should," and other expressions that indicate future events and trends identify such forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause the outcome and future results of operations and financial condition to be materially different than stated or anticipated based on the forward-looking statements. Such risks and uncertainties include both general economic risks and uncertainties, risks and uncertainties affecting the demand for and economic factors affecting the delivery of health care services, and specific matters which relate directly to the Company's operations and properties as discussed in its periodic filings with the Securities and Exchange Commission. The Company cautions that any forward-looking statement contained in this report reflects only the belief of the Company or its management at the time the statement was made. Although the Company believes such forward-looking statements are based upon reasonable assumptions, such assumptions may ultimately prove inaccurate or incomplete. The Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement was made.ALLIED HEALTHCARE PRODUCTS, INC.CONSOLIDATED STATEMENT OF OPERATIONS(UNAUDITED)Three months ended,Six months ended,December 31,December 31,2010200920102009Net sales

$11,402,681$11,414,908$23,343,414$22,738,584Cost of sales

8,592,7128,470,16917,982,71817,390,969Gross profit

2,809,9692,944,7395,360,6965,347,615Selling General and administrative expenses

2,600,7342,900,1135,285,3106,491,891Income (loss) from operations

209,23544,62675,386(1,144,276)Interest income

(8,067)(464)(15,542)(1,448)Interest expense

-162662,574Other, net

28,41011,78543,50922,79820,34311,48328,03323,924Income (loss) before provision for(benefit from) income taxes

188,89233,14347,353(1,168,200)Provision for (benefit from) income taxes

71,77911,57317,994(444,832)Net income (loss)

$117,113$21,570$29,359($723,368)Net income (loss) per share - Basic

$0.01$0.00$0.00($0.09)Net income (loss) per share - Diluted

$0.01$0.00$0.00($0.09)Weighted average common shares outstanding - Basic

8,098,3668,092,7348,095,8768,040,528Weighted average common shares outstanding - Diluted

8,119,3868,217,1038,114,7248,040,528ALLIED HEALTHCARE PRODUCTS, INC.CONSOLIDATED BALANCE SHEET(UNAUDITED)December 31, 2010June 30, 2010ASSETSCurrent assets:Cash and cash equivalents

$6,239,426$5,263,324Accounts receivable, net of allowances  of $300,000

4,224,9755,418,253Inventories, net

11,423,93311,155,456Income tax receivable

811,347877,665Other current assets

237,635221,840Total current assets

22,937,31622,936,538Property, plant and equipment, net

9,015,1079,661,395Other assets, net

326,961333,084Total assets

$32,279,384$32,931,017LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Accounts payable

$
2,123,410$   1,950,446Other accrued liabilities

1,653,5192,241,259Deferred income taxes

425,036429,699Deferred revenue

688,200688,200Total current liabilities

4,890,1655,309,604Deferred revenue458,800802,900Commitments and contingenciesStockholders' equity:Preferred stock; $0.01 par value; 1,500,000 shares  authorized; no shares issued and outstanding

--Series A preferred stock; $0.01 par value; 200,000 shares  authorized; no shares issued and outstanding

--Common stock; $0.01 par value; 30,000,000 shares  authorized; 10,415,709 and 10,396,878  shares issued  at December 31, 2010 and June 30, 2010, respectively;  8,112,217 and 8,093,386 shares outstanding at  December 31, 2010 and June 30, 2010, respectively

104,157103,969Additional paid-in capital

48,445,28148,362,922Accumulated deficit

(887,591)(916,950)Less treasury stock, at cost; 2,303,492 shares at   December 31, 2010 and June 30, 2010, respectively

(20,731,428)(20,731,428)Total stockholders' equity

26,930,41926,818,513Total liabilities and stockholders' equity

$32,279,384$32,931,017
'/>"/>

SOURCE Allied Healthcare Products, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Recession Continues to Depress Sales at Allied Healthcare Products
2. Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions
3. Allied Healthcare Announces Litholyme(TM) -- New CO2 Absorbent Used in Anesthesia
4. Recession Leads to Sales Decline and Loss for Allied Healthcare Products in Fiscal 2010
5. Allied Telesis, Hosted PACS Solutions Join Forces to Deliver Managed Cloud-Based Picture Archiving and Communications Systems (PACS) Services
6. Allied Healthcare Products Reports Narrow Loss for Quarter But Improves Year-Over-Year Performance
7. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
8. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
9. ViroPharma to Present at Three Upcoming Healthcare Conferences
10. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
11. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... 2016  Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ) ... development of a once-daily, oral therapy for the treatment ... Officer, Dr. Maya Halpern , has notified the Company ... Officer and from its Board of Directors effective as ... age. Allen Baharaff . Mr. Baharaff continued, ...
(Date:2/11/2016)... Germany , February 11, 2016 ... up 6.8% to EUR 1,377.2m  Adjusted EBITDA climbs to ... 18.0% to EUR 3.41  Proposed dividend of EUR 0.85 ... sale of glass tubing business and refinancing successfully completed  ... to 5% on organic basis  Adjusted EBITDA expected ...
(Date:2/10/2016)... in the U.S. and Europe , announced ... laser at the upcoming 151 st Midwinter Meeting of ... #4815. The ST PRO is a full featured hard and ... the award winning, industry leading Lightwalker ATS. At an introductory price ... attractive to many dentists hesitating to incorporate lasers into their ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... ... as the World Molecular Imaging Congress (WMIC), will be held in New York ... meeting is “Imaging Biology…Improving Therapy.” The congress will highlight and emphasize how imaging ...
(Date:2/10/2016)... California (PRWEB) , ... February 10, 2016 , ... ... are working together to expand dental health services to the developmentally disabled in ... We Care Dental’s operations to a new facility at 71-949 Highway 111, Suite ...
(Date:2/10/2016)... ... February 10, 2016 , ... Compliancy Group LLC ... of medical professionals throughout the country. The Guard was specifically designed to handle ... procedures, employee training, regulatory updates, and compliance coaching. , In addition to meeting ...
(Date:2/10/2016)... , ... February 10, 2016 , ... Dr. Jessica Barron, ... practice is now accepting new dental patients and families in the North Metro Denver ... care services from cleanings to cosmetic dentistry, and all in the most relaxing environment. ...
(Date:2/10/2016)... ... ... AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the ... ended December 31, 2015 on Monday, February 29, 2016 after the market closes. , ... the release at 4:30 PM ET. Investors interested in participating by phone are invited ...
Breaking Medicine News(10 mins):